共 230 条
[1]
Ray JG(2005)Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study Lancet 366 1797-1803
[2]
Vermeulen MJ(2006)Adult consequences of fetal growth restriction Clin Obstet Gynecol 49 270-283
[3]
Schull MJ(2008)Effect of in utero and early-life conditions on adult health and disease N Engl J Med 359 61-73
[4]
Redelmeier DA(2004)First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial) Am J Obstet Gynecol 191 1446-1451
[5]
Barker DJ(2009)First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome Prenat Diagn 29 553-559
[6]
Gluckman PD(2007)Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11–14 weeks' gestation Ultrasound Obstet Gynecol 29 135-140
[7]
Hanson MA(2000)First-trimester maternal serum free beta-human chorionic gonadotropin and pregnancy associated plasma protein-A as predictors of pregnancy complications Bjog-an International Journal of Obstetrics and Gynaecology 107 1265-1270
[8]
Cooper C(2007)First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia Ultrasound Obstet Gynecol 29 128-134
[9]
Thornburg KL(2010)Free leptin index and PAPP-A: a first trimester maternal serum screening test for pre-eclampsia Prenat Diagn 30 103-109
[10]
Dugoff L(2002)Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth J Clin Endocrinol Metab 87 1762-1767